.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Triamcinolone - Generic Drug Details

« Back to Dashboard
Triamcinolone is the generic ingredient in twenty-eight branded drugs marketed by Sandoz, Mylan, Roxane, Barr, Purepac Pharm, Watson Labs, Impax Labs, Ivax Sub Teva Pharms, Astellas, Teva, Delcor Asset Corp, Apothecon, Taro, Parnell, Teva Pharms, Ranbaxy Labs Ltd, Teligent Pharma Inc, Pharmafair, Versapharm Inc, Solvay, Perrigo New York, Alpharma Us Pharms, Abbvie, Glenmark Pharms Ltd, Allergan, Lupin Atlantis, Ivax Pharms, G And W Labs Inc, Ambix, Crown Labs, Alcon, Wockhardt Eu Operatn, Wockhardt, Sandoz Canada Inc, Fougera Pharms, Sanofi Aventis Us, Vintage, Lyne, Topiderm, Perrigo Uk Finco, Pharmaderm, Morton Grove, Savage Labs, G And W Labs, Carolina Medcl, Actavis Mid Atlantic, and Akorn, and is included in one hundred and forty-one NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are forty-nine drug master file entries for triamcinolone.

Summary for Generic Name: triamcinolone

Tradenames:28
Patents:6
Applicants:47
NDAs:141
Drug Master File Entries: see list49
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Inflammatory Bowel Disease Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astellas
ARISTOCORT
triamcinolone diacetate
SYRUP;ORAL011960-004Approved Prior to Jan 1, 1982DISCNNo► subscribe► subscribe
Akorn
TRIAMCINOLONE DIACETATE
triamcinolone diacetate
INJECTABLE;INJECTION086394-001Approved Prior to Jan 1, 1982DISCNNo► subscribe► subscribe
Delcor Asset Corp
KENACORT
triamcinolone
TABLET;ORAL011283-010Approved Prior to Jan 1, 1982DISCNNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc